Mattias Mandorfer

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Jonel Trebicka, Javier Fernández, Mária Papp et al. · Journal of Hepatology · 2020 · 478 citations · Full text

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

Mattias Mandorfer, Simona Bota, Philipp Schwabl et al. · Gastroenterology · 2014 · 369 citations

Hepatology, Liver Physiology, Hepatorenal Syndrome +10

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

Thomas Reiberger, Arnulf Ferlitsch, B.A. Payer et al. · Journal of Hepatology · 2012 · 318 citations

Inflammation, Intestinal Permeability, Non-selective Betablocker Therapy +11

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Mattias Mandorfer, K Kozbial, Philipp Schwabl et al. · Journal of Hepatology · 2016 · 298 citations

Hepatology, Viral Hepatitis, Immunology +8

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 284 citations · Full text